💼 Business 3h ago · Investing.com

Engene stock maintains Outperform rating on bladder cancer data

Investing.com News
Latest updates on stocks, forex, and commodities
View Channel →
Engene stock maintains Outperform rating on bladder cancer data
Source ↗ 👁 1 💬 0

Comments (0)

Sign in to join the discussion

More Like This

Kraft Heinz is projecting a return to sales growth in second-half 2027
Quartz · 2h ago
Some under-25s should get fewer benefits, Milburn review to say
BBC News · 2h ago
Canada's ambassador warned Trump's tariffs are raising the cost of investment
Quartz · 2h ago
CoreWeave is planning to raise at least $4 billion in a new high-grade loan
Quartz · 2h ago
Nvidia's board is preparing to oust Jensen Huang over two affairs
Quartz · 2h ago
Bitcoin slips to about $73,000 as Nvidia CEO turmoil rattles risk appetite
Quartz · 2h ago